In the United States, there are over 60,000 new diagnoses and nearly 14,000 deaths from kidney cancer each year. The treatment landscape is quickly evolving. Join us to learn more...
In the United States, there are over 60,000 new diagnoses and nearly 14,000 deaths from kidney cancer each year. The treatment landscape is quickly evolving. Join us to learn more...
Breast Cancer experts lead a discussion on incorporating newly approved drugs into the breast cancer treatment armamentarium focusing on what is Standard of Care.
In the United States, there are over 60,000 new diagnoses and nearly 14,000 deaths from kidney cancer each year. The treatment landscape is quickly evolving. Join us to learn more...
With therapeutic advances in lung cancer coming fast and furious, hear from recognized lung cancer experts on how the treatment landscape is evolving. Must be a healthcare professional to attend.
The Who, When, Where, and How of PARP Inhibition. Linking the biology, the disease, and the treatment.
With therapeutic advances in lung cancer coming fast and furious, hear from recognized lung cancer experts on how the treatment landscape is evolving. Must be a healthcare professional to attend.
In the United States, there are over 60,000 new diagnoses and nearly 14,000 deaths from kidney cancer each year. The treatment landscape is quickly evolving. Join us to learn more...
Breast Cancer experts lead a discussion on incorporating newly approved drugs into the breast cancer treatment armamentarium focusing on what is Standard of Care.
Breast Cancer experts lead a discussion on incorporating newly approved drugs into the breast cancer treatment armamentarium focusing on what is Standard of Care.
With therapeutic advances in lung cancer coming fast and furious, hear from recognized lung cancer experts on how the treatment landscape is evolving. Must be a healthcare professional to attend.
